SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Linike Medical Group Ltd LNMG OTC

Other OTC • Financial Services • Shell Companies • CA • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Linike Medical Group Ltd (LNMG) is a Shell Companies company in the Financial Services sector, currently trading at $0.03. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Financials: revenue is $13M, +45.7%/yr average growth. Net income is $244,879 (loss), growing at +452.1%/yr. Net profit margin is -1.9% (negative). Gross margin is 99.6% (+0.3 pp trend).

Balance sheet: total debt is $18M against $35M equity (Debt-to-Equity (D/E) ratio 0.52, moderate). Current ratio is 3.04 (strong liquidity). Debt-to-assets is 32.7%. Total assets: $56M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 100/100 (Pass), Past 25/100 (Fail), Health 75/100 (Pass), Moat 46/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

LNMG SharesGrow Score Overview

51/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 100/100

Financials — average growth

PAST 25/100

strong — trend

HEALTH 75/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 46/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — LNMG

No analyst coverage available for this stock.

LNMG: +45.7%/yr revenue is, +452.1%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

LNMG: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet LNMG: Debt-to-Equity (D/E) ratio 0.52 (moderate), Current ratio is 3.04 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

LNMG: Gross margin is 99.6% (+0.3 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 46/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

LNMG: Net profit margin is -1.9%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.0028-0.045

Volume25

Avg Volume (30D)2.66K

Market Cap$12.99M

Beta (1Y)-5.13

Share Statistics

EPS (TTM)0.00

Shares Outstanding$668.95M

IPO Date2012-06-12

CEOEric David Lawson

Financial Highlights & Ratios

Revenue (TTM)$13.05M

Gross Profit$12.99M

EBITDA$-189.76K

Net Income$-244.88K

Operating Income$-244.88K

Total Cash$687.91K

Total Debt$18.18M

Net Debt$17.5M

Total Assets$55.65M

Price / Earnings (P/E)-63.8

Price / Sales (P/S)1

Analyst Forecast

Company Info

CountryCA

ExchangeOther OTC

CurrencyUSD

ISINUS53577J1007

Price Chart

LNMG

Linike Medical Group Ltd ↗ · Other OTC

Financial Services • Shell Companies

0.00 52WK RANGE 0.05

People Also View

Vanguard Total Stock Market Index Fund Institutional Shares

Vanguard Total Stock Market Index Fund Admiral Shares

Vanguard Total Stock Market Index Fund Institutional Plus Shares

PIMCO Flexible Municipal Income Fund

Vanguard S&P 500 ETF

Vanguard 500 Index Fund

Vanguard 500 Index Fund Admiral Shares

Vanguard 500 Index Fund

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message